These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 31685442

  • 1. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
    Seo D, Jung SM, Park JS, Lee J, Ha J, Kim M, Park SH.
    EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
    [Abstract] [Full Text] [Related]

  • 2. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
    Jing C, Duan Y, Zhou M, Yue K, Zhuo S, Li X, Liu D, Ye B, Lai Q, Li L, Yao X, Wei H, Zhang W, Wu Y, Wang X.
    Theranostics; 2021 Nov; 11(6):2655-2669. PubMed ID: 33456565
    [Abstract] [Full Text] [Related]

  • 3. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C, Li X, Zhou M, Zhang S, Lai Q, Liu D, Ye B, Li L, Wu Y, Li H, Yue K, Chen P, Yao X, Wu Y, Duan Y, Wang X.
    Theranostics; 2021 Nov; 11(12):5847-5862. PubMed ID: 33897885
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Deubiquitinating enzyme PSMD14 facilitates gastric carcinogenesis through stabilizing PTBP1.
    Li J, Li Y, Xu F, Sun B, Yang L, Wang H.
    Exp Cell Res; 2022 Jun 15; 415(2):113148. PubMed ID: 35405117
    [Abstract] [Full Text] [Related]

  • 8. Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC.
    Zhao Z, Xu H, Wei Y, Sun L, Song Y.
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb 15; 1869(2):166594. PubMed ID: 36328147
    [Abstract] [Full Text] [Related]

  • 9. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
    Luo Q, Wu X, Nan Y, Chang W, Zhao P, Zhang Y, Su D, Liu Z.
    Cell Rep; 2020 Jan 07; 30(1):98-111.e5. PubMed ID: 31914402
    [Abstract] [Full Text] [Related]

  • 10. BMP signaling pathways affect differently migration and invasion of esophageal squamous cancer cells.
    Hu M, Cui F, Liu F, Wang J, Wei X, Li Y.
    Int J Oncol; 2017 Jan 07; 50(1):193-202. PubMed ID: 27959431
    [Abstract] [Full Text] [Related]

  • 11. ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.
    Zhi T, Jiang K, Xu X, Yu T, Zhou F, Wang Y, Liu N, Zhang J.
    Neuro Oncol; 2019 Mar 18; 21(4):462-473. PubMed ID: 30590814
    [Abstract] [Full Text] [Related]

  • 12. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.
    Sun T, Liu Z, Bi F, Yang Q.
    Mol Oncol; 2021 Dec 18; 15(12):3639-3658. PubMed ID: 34382324
    [Abstract] [Full Text] [Related]

  • 13. SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells.
    Yang H, Yu N, Xu J, Ding X, Deng W, Wu G, Li X, Hou Y, Liu Z, Zhao Y, Xue M, Yu S, Wang B, Li X, Niu G, Wang H, Zhu J, Zhuang T.
    J Exp Clin Cancer Res; 2018 Feb 12; 37(1):24. PubMed ID: 29433542
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
    Zhang HT, Zeng LF, He QY, Tao WA, Zha ZG, Hu CD.
    Biochim Biophys Acta; 2016 Feb 12; 1863(2):335-46. PubMed ID: 26658161
    [Abstract] [Full Text] [Related]

  • 16. Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells.
    Song W, Li Z, Xia M, Xiao W.
    Oncol Rep; 2024 Jan 12; 51(1):. PubMed ID: 37975230
    [Abstract] [Full Text] [Related]

  • 17. Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence.
    Benn A, Hiepen C, Osterland M, Schütte C, Zwijsen A, Knaus P.
    FASEB J; 2017 Nov 12; 31(11):4720-4733. PubMed ID: 28733457
    [Abstract] [Full Text] [Related]

  • 18. ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2.
    Traeger L, Gallitz I, Sekhri R, Bäumer N, Kuhlmann T, Kemming C, Holtkamp M, Müller JC, Karst U, Canonne-Hergaux F, Muckenthaler MU, Bloch DB, Olschewski A, Bartnikas TB, Steinbicker AU.
    Free Radic Biol Med; 2018 Dec 12; 129():127-137. PubMed ID: 30227271
    [Abstract] [Full Text] [Related]

  • 19. The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.
    He L, Yu C, Qin S, Zheng E, Liu X, Liu Y, Yu S, Liu Y, Dou X, Shang Z, Wang Y, Wang Y, Zhou X, Liu B, Zhong Y, Liu Z, Lu J, Sun L.
    Mol Cell; 2023 Nov 16; 83(22):4000-4016.e6. PubMed ID: 37935198
    [Abstract] [Full Text] [Related]

  • 20. Novel insights into the non-canonical roles of PSMD14/POH1/Rpn11 in proteostasis and in the modulation of cancer progression.
    Bustamante HA, Albornoz N, Morselli E, Soza A, Burgos PV.
    Cell Signal; 2023 Jan 16; 101():110490. PubMed ID: 36241058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.